Skip to content

End-to-end deployment and support for clinical studies

Validated solution for nocturnal monitoring in clinical trials

Seamless integration into clinical studies with no burden on participants or study sites

Albus Home is a clinically validated contactless monitor that passively collects multiple digital biomarkers without any reliance on participant compliance. The system is designed by clinical investigators and research nurses to maximise reliability and minimise burden for study teams.
Learn more about Our Solution
医療テクノロジー

Addressing Data Challenges in Clinical Trials

Seamless Monitoring for Reliable Results

Clinical trials often struggle with incomplete datasets and recall bias due to reliance on intermittent clinic visits and participant self-reporting. Albus Health’s passive monitoring technology offers a transformative solution: continuous, contactless data collection that captures objective, real-world evidence across multiple therapies. Our system enables the measurement of respiratory endpoints and digital biomarkers, supporting both site-based and decentralised study designs, all without adding burden to participants.

  • Data gaps from self-reporting and sporadic clinic visits
  • Participant burden causing higher drop-out rates and protocol deviations
  • Limited insight into symptom variability and long-term disease progression
  • Inefficiencies from manual data handling and device logistics

With Albus Health, clinical trials benefit from richer, more complete data, improved participant retention, and streamlined operations, empowering researchers to achieve more nuanced and impactful outcomes.

Clinical Trials digital dial

It’s been super easy to explain the device, and participants get it really quickly. In fact, it’s the easiest out of all the study devices we give them.

The others need a lot of training or explanations especially for some of the older patients.

Research Nurse in clinical study using

Albus Home RD

Our solution combines advanced multi-sensor technology, signal processing and machine learning to deliver reliable, clinical-grade data

Contactless and automated

Nothing to do or wear; simply position the device at the bedside

Multi-sensor, multi- metric

Unmatched* broad range of physiological and environmental metrics from the same device

Clinical-grade accuracy

Validated in real-world environment against clinical gold-standards

Remote monitoring / No infrastructure required

Worldwide data collection via WiFi and in-built SIM (cellular) connection.

Plug and play: Paediatrics to Geriatrics

Suitable for patients of all demographics from children to the elderly.

Connects 3rd party devices

Build-in Bluetooth enables connections to external devices like pulse oximeters

Web dashboard

Allows researchers to easily manage and track data collection

Privacy preserving

Speech is automatically removed by device before data is stored.

Secure and compliant

Data is encrypted at all stages; compliant to international standards (incl. GCP)

Why night-time monitoring?

Our publications on contactless and automated respiratory rate and cough monitoring are found below. Please get in touch with us to find out more about other metrics we monitor and related evidence.

Contactless and automated monitoring to study changes in nocturnal parameters before and after asthma attacks in children

British Thoracic Society Winter Meeting 2024, Thorax 2024;79:A63-A64

P. Nagakumar, W. Do, M. Udani, O. Carr, L. Fleming, and S. Saglani

Read full article
Contactless and automated monitoring to study changes in nocturnal parameters before and after asthma attacks in children

Pediatric nocturnal respiratory rate monitoring using a non-contact and passive bedside device: accuracy of the Albus Home Research Device (RD).

American Journal of Respiratory and Critical Care Medicine 2021;203:A3464

Wheeler, C., Do, W., De Vos, M., Russell, R. and Bafadhel, M.

Read full article
Pediatric nocturnal respiratory rate monitoring using a non-contact and passive bedside device: accuracy of the Albus Home Research Device (RD).

Globally certified and deployed.

asset-map-updated (1)
5bn

Data points recorded

Across all global trials

12+

Parameters recorded

With one compact device

24

Countries certified

including CE, FCC, UKCA. Additional countries pending in Q4 2025

Frequently asked questions

Got a question about Albus Home HD, about us, or any of our services? Check out our FAQs, or get in touch.

A dedicated Project Manager will be allocated for the whole duration of the study, ensuring smooth coordination, timely updates, and continuous support from start to finish.

No extra infrastructure or technical setup is required for either the sites or the participants, ensuring swift deployment.

All study sites are provided with all required equipment including devices, pre‑configured Wi‑Fi hubs, and bedside accessories. No additional equipment is required.

Albus Health uses end‑to‑end encryption and complies with GDPR and HIPAA requirements. No personally identifiable data is stored on the device, ensuring participant privacy.

Yes. Albus Home is fully compatible with decentralised clinical trials, securely transmitting data to trial dashboards without the need for regular site visits or complex technical setup.

Advancing clinical trials across a range of therapeutic areas

We support research and pharma teams with scalable, patient-friendly monitoring for decentralised clinical trials across multiple therapeutic areas. Our contactless technology delivers high-quality data, improves adherence, and speeds endpoint validation.